Protara Therapeutics Inc’s recently made public that its Director Levy Richard S acquired Company’s shares for reported $63800.0 on May 14 ’25. In the deal valued at $3.19 per share,20,000 shares were bought. As a result of this transaction, Levy Richard S now holds 51,000 shares worth roughly $0.27 million.
Then, Zummo Jacqueline sold 21,224 shares, generating $96,145 in total proceeds. Upon selling the shares at $4.53, the Chf Scientific Operations Off now owns 98,861 shares.
Before that, Zummo Jacqueline bought 21,224 shares. Protara Therapeutics Inc shares valued at $96,569 were divested by the Officer at a price of $4.55 per share.
Scotiabank initiated its Protara Therapeutics Inc [TARA] rating to a Sector outperform in a research note published on April 16, 2025; the price target was $12. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. H.C. Wainwright started covering the stock on June 04, 2021. It rated TARA as “a Buy”.
Price Performance Review of TARA
On Monday, Protara Therapeutics Inc [NASDAQ:TARA] saw its stock jump 2.30% to $5.34. Over the last five days, the stock has gained 9.65%. Protara Therapeutics Inc shares have risen nearly 215.98% since the year began. Nevertheless, the stocks have risen 1.14% over the past one year.
How much short interest is there in Protara Therapeutics Inc?
A steep rise in short interest was recorded in Protara Therapeutics Inc stocks on 2025-09-30, dropping by -0.53 million shares to a total of 2.46 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-29 was 2.99 million shares. There was a decline of -21.41%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 17, 2021 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $43 price target.
